Biomechanics of accommodation
住宿生物力学
基本信息
- 批准号:10441503
- 负责人:
- 金额:$ 58.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgeAnatomyAnimalsBiomechanicsBiometryClinicClinicalCouplingCrystalline LensCustomDataDevelopmentDevicesElasticityEyeGoalsHumanImaging DeviceInvestigationKnowledgeLens developmentMeasurableMeasurementMeasuresMechanicsMethodsMicroscopyModalityMonitorOptical Coherence TomographyOptical InstrumentOpticsOryctolagus cuniculusOutcomePhysiologyPreclinical TestingPresbyopiaProceduresQuality of lifeResearch DesignRetreatmentRoleStressStretchingSurfaceSystemTechniquesTechnologyTestingTherapeutic procedureTimeTissuesTreatment outcomeValidationVisionage relatedbiomechanical modeldesignelastographyfunctional outcomeshuman subjectimage guidedin vivoinstrumentinstrumentationlensmechanical propertiesmultidisciplinarymultimodalitynew technologynovelpreservationresearch clinical testingtreatment effecttreatment optimization
项目摘要
PROJECT ABSTRACT
Presbyopia, the progressive age-related loss of near visual function, is associated with a stiffening of the
crystalline lens. There are currently several investigational approaches for presbyopia treatment that rely on lens
softening or lens replacement with softer materials. Lens softening approaches are expected to have a
transformative impact on the field because they are non-invasive and they preserve the anatomical relationship
between the lens and other tissues involved in accommodation. They have therefore the potential to restore the
natural dynamic accommodative function. However, one of the fundamental roadblocks towards the
development of lens softening procedures is that there is currently no method available to directly measure lens
stiffness and thus assess the efficacy of lens softening procedures in vivo.
The goal of the project is to develop new technology capable of precise spatially-resolved non-destructive,
noninvasive and depth-resolved quantitative measurements of the lens mechanical properties in a clinical
setting. The technology will combine Brillouin microscopy, Optical Coherence Tomography (OCT), and Optical
Coherence Elastography (OCE) - BOE. The instrument will be used to generate the first age-dependent data on
lens mechanical properties quantified in vivo as well as quantitatively assess therapeutic procedures aimed to
restore accommodation.
Our overall hypothesis is that the novel BOE technology can acquire absolute measurements of the lens stiffness
gradient with the accuracy and precision required to detect both age-related changes and changes induced by
lens softening treatments. The ability to quantify lens softening in vivo will have a major impact on pre-clinical
and clinical testing, validation and optimization of lens softening procedures.
The project has three specific aims:
Aim 1: Develop a combined BOE imaging device for depth-resolved quantitative lens elastography.
Aim 2: Validate BOE measurements in animal and human lens ex vivo and animal lens in vivo.
Aim 3: Quantify the mechanical properties of the human lens in vivo
To accomplish our objective, we have assembled a multidisciplinary team with expertise in optical coherence
tomography and elastography (Larin), Brillouin technology (Scarcelli), biomechanical modeling (Aglyamov),
clinical ophthalmic instrumentation and crystalline lens physiology (Manns, Parel, Ruggeri, Yoo).
项目摘要
老花眼是一种与年龄相关的近视功能逐渐丧失的现象,与视神经的僵化有关。
晶状体。目前有几种依赖晶状体治疗老花眼的研究方法
软化或用较软的材料更换镜片。镜片软化方法预计具有
对该领域产生变革性影响,因为它们是非侵入性的并且保留了解剖关系
晶状体和其他参与调节的组织之间。因此,他们有潜力恢复
自然动态调节功能。然而,实现这一目标的根本障碍之一是
镜片软化程序的发展是目前没有可用的方法来直接测量镜片
硬度,从而评估体内晶状体软化程序的功效。
该项目的目标是开发能够精确空间分辨无损、
临床中晶状体机械性能的无创和深度分辨定量测量
环境。该技术将结合布里渊显微镜、光学相干断层扫描(OCT)和光学
相干弹性成像 (OCE) - BOE。该仪器将用于生成第一个与年龄相关的数据
体内量化晶状体机械特性以及定量评估治疗程序旨在
恢复住宿。
我们的总体假设是,新颖的京东方技术可以获得镜片刚度的绝对测量
梯度具有检测与年龄相关的变化和由年龄引起的变化所需的准确性和精确度
镜片软化处理。体内量化晶状体软化的能力将对临床前产生重大影响
以及晶状体软化程序的临床测试、验证和优化。
该项目有三个具体目标:
目标 1:开发用于深度分辨定量透镜弹性成像的组合 BOE 成像装置。
目标 2:验证离体动物和人类晶状体以及体内动物晶状体的 BOE 测量结果。
目标 3:量化人体晶状体体内的机械特性
为了实现我们的目标,我们组建了一支具有光学相干专业知识的多学科团队
断层扫描和弹性成像 (Larin)、布里渊技术 (Scarcelli)、生物力学建模 (Aglyamov)、
临床眼科仪器和晶状体生理学(Manns、Parel、Ruggeri、Yoo)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirill V Larin其他文献
Specificity of noninvasive blood glucose sensing using optical coherence tomography technique: a pilot study
使用光学相干断层扫描技术进行无创血糖传感的特异性:一项试点研究
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:0
- 作者:
Kirill V Larin;Massoud Motamedi;Taras V Ashitkov;Rinat O Esenaliev - 通讯作者:
Rinat O Esenaliev
Kirill V Larin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirill V Larin', 18)}}的其他基金
No-Touch High Resolution Optical Coherence Elastography of the Cornea using a Heartbeat
使用心跳进行角膜非接触式高分辨率光学相干弹性成像
- 批准号:
10534861 - 财政年份:2022
- 资助金额:
$ 58.2万 - 项目类别:
No-Touch High Resolution Optical Coherence Elastography of the Cornea using a Heartbeat
使用心跳进行角膜非接触式高分辨率光学相干弹性成像
- 批准号:
10705274 - 财政年份:2022
- 资助金额:
$ 58.2万 - 项目类别:
Prenatal alcohol/cannabinoid co-exposures and fetal brain development
产前酒精/大麻素共同暴露与胎儿大脑发育
- 批准号:
10827625 - 财政年份:2020
- 资助金额:
$ 58.2万 - 项目类别:
Prenatal alcohol/cannabinoid co-exposures and fetal brain development
产前酒精/大麻素共同暴露与胎儿大脑发育
- 批准号:
10517743 - 财政年份:2020
- 资助金额:
$ 58.2万 - 项目类别:
Prenatal alcohol/cannabinoid co-exposures and fetal brain development
产前酒精/大麻素共同暴露与胎儿大脑发育
- 批准号:
10397066 - 财政年份:2020
- 资助金额:
$ 58.2万 - 项目类别:
Prenatal alcohol/cannabinoid co-exposures and fetal brain development
产前酒精/大麻素共同暴露与胎儿大脑发育
- 批准号:
10615680 - 财政年份:2020
- 资助金额:
$ 58.2万 - 项目类别:
Prenatal alcohol/cannabinoid co-exposures and fetal brain development
产前酒精/大麻素共同暴露与胎儿大脑发育
- 批准号:
10616046 - 财政年份:2020
- 资助金额:
$ 58.2万 - 项目类别:
相似国自然基金
儿童脊柱区腧穴针刺安全性的发育解剖学及三维数字化研究
- 批准号:82360892
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
寰枢椎脱位后路钉棒内固定系统复位能力优化的相关解剖学及生物力学研究
- 批准号:82272582
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于次生乳管网络结构发育比较解剖学和转录组学的橡胶树产胶机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于垂体腺瘤海绵窦侵袭模式的相关膜性解剖学及影像学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
亚热带典型阔叶树种径向生长的解剖学特征及其碳分配调控机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Reversibility of brain glucose kinetics in type 2 diabetic subjects
2 型糖尿病受试者脑葡萄糖动力学的可逆性
- 批准号:
10664102 - 财政年份:2023
- 资助金额:
$ 58.2万 - 项目类别:
Individualized Profiles of Sensorineural Hearing Loss from Non-Invasive Biomarkers of Peripheral Pathology
周围病理学非侵入性生物标志物的感音神经性听力损失个体化概况
- 批准号:
10827155 - 财政年份:2023
- 资助金额:
$ 58.2万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 58.2万 - 项目类别:
Therapeutic Strategy to Treat Alzheimer's Disease by VGF Delivery into Brain
通过将 VGF 输送至大脑来治疗阿尔茨海默病的治疗策略
- 批准号:
10738951 - 财政年份:2023
- 资助金额:
$ 58.2万 - 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:
10602826 - 财政年份:2023
- 资助金额:
$ 58.2万 - 项目类别: